Poonam Dharmani-Khan

发表

Influence of Chemotherapy on Allergen-Specific IgE

J. Storek, F. Khan, S. Whiteside, 2018, International Archives of Allergy and Immunology.

Immune cell subset counts associated with graft-versus-host disease.

J. Storek, J. Luider, A. Mansoor, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of abacavir‐specific effector and proliferating functions of CD8 T cells in abacavir‐treated HIV‐1 patients

J. Gill, Stuti N Patel, F. Khan, 2019, Microbiology and immunology.

A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin.

J. Storek, A. Kalra, F. Khan, 2021, Cytotherapy.

Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin.

D. Mahoney, J. Storek, V. Jimenez-Zepeda, 2019, Blood advances.

High serum level of antithymocyte globulin immediately before graft infusion is associated with a low likelihood of chronic, but not acute, graft-versus-host disease.

C. Griffiths, J. Storek, D. Stewart, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Curability and transferability of atopy with allogeneic hematopoietic cell transplantation

S. Spellman, J. Brandwein, R. Leigh, 2020, Bone Marrow Transplantation.

Mild clinical course of SARS-coronavirus-2 infection early posttransplant in patients with adoptively transferred antibody response

J. Kanji, J. Storek, A. Kalra, 2021, Bone Marrow Transplantation.

Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease.

J. Storek, P. Duggan, V. Jimenez-Zepeda, 2022, Cytotherapy.

Risk factors for the incidence of PTLD and the mortality due to PTLD after hematopoietic cell transplantation.

J. Storek, P. Duggan, V. Jimenez-Zepeda, 2021, Transplantation and cellular therapy.

High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.

J. Storek, P. Duggan, J. Tay, 2019, Cytotherapy.

Low Counts of B Cells, Natural Killer Cells, Monocytes, Dendritic Cells, Basophils, and Eosinophils are Associated with Postengraftment Infections after Allogeneic Hematopoietic Cell Transplantation.

J. Storek, J. Luider, A. Mansoor, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hematopoietic cell transplant outcomes after myeloablative conditioning with fludarabine, busulfan, low‐dose total body irradiation, and rabbit antithymocyte globulin

J. Storek, P. Duggan, V. Jimenez-Zepeda, 2020, Clinical transplantation.

Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency.

C. Overall, C. Sergi, S. Turvey, 2021, The Journal of allergy and clinical immunology.

Antithymocyte Globulin at Clinically Relevant Concentrations Kills Leukemic Blasts.

J. Brandwein, J. Storek, J. Luider, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor Genetic Predisposition to High Interleukin-10 Production Appears Protective against Acute Graft-Versus-Host Disease

J. Storek, A. Kalra, G. Tripathi, 2022, International journal of molecular sciences.

Rabbit Antithymocyte Globulin Serum Levels: Factors Impacting the Levels and Clinical Outcomes Impacted by the Levels.

J. Storek, J. Luider, F. Khan, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation

J. Storek, R. Rajalingam, G. Tripathi, 2016, PloS one.

Title Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative , HLA Matched Hematopoietic Cell Transplantation

J. Storek, R. Rajalingam, G. Tripathi, 2016 .

High incidence of hematologic malignancy relapse after allogeneic transplantation in patients with low Epstein-Barr virus-specific T-cell counts.

R. Tellier, J. Storek, A. Kalra, 2019, Cytotherapy.

Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19

J. C. Cohen Tervaert, J. Storek, A. Kalra, 2020, Blood Advances.

Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy

J. Luider, A. Shameli, Poonam Dharmani-Khan, 2020, Cytometry. Part B, Clinical cytometry.

Anti-thymocyte globulin’s activity against acute myeloid leukemia stem cells

J. Brandwein, J. Storek, J. Luider, 2018, Bone Marrow Transplantation.

Lack of both donor and recipient anti-EBV T cells in EBV seronegative recipients of grafts from seropositive donors

J. Storek, A. Kalra, G. Tripathi, 2022, Bone Marrow Transplantation.

Deep immunophenotypic analysis of the bone marrow progenitor cells in myelodysplastic syndromes.

Poonam Dharmani-Khan, M. Shabani‐Rad, Afshin Shameli, 2023, Leukemia research.